๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours

โœ Scribed by Winfried Brenner; Reinhard E. Friedrich; Karim A. Gawad; Christian Hagel; Andreas von Deimling; Maike de Wit; Ralph Buchert; Malte Clausen; Victor F. Mautner


Publisher
Springer
Year
2006
Tongue
English
Weight
109 KB
Volume
33
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Constitutional NF1 mutations in neurofib
โœ Lan Kluwe; Reinhard E. Friedrich; Matthias Peiper; Jan Friedman; Victor-F. Mautn ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 32 KB

Neurofibromatosis type 1 (NF1) patients have 10% of lifetime risk for developing malignant peripheral nerve sheath tumors (MPNST), one of the most aggressive cancers. We examined the spectrum of constitutional NF1 mutations among 24 NF1 patients with MPNST. We found mutations in 18 patients: four me

Microarray-based copy number analysis of
โœ Meena Upadhyaya; Gill Spurlock; Laura Thomas; Nick S. T. Thomas; Mark Richards; ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 479 KB ๐Ÿ‘ 1 views

Neurofibromatosis type-1 (NF1) is associated with the growth of benign and malignant tumors. Approximately 15% of NF1 patients develop malignant peripheral nerve sheath tumors (MPNSTs), underlining the need to identify specific diagnostic/prognostic biomarkers associated with MPNST development. The